Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


12.06.2017

11 Ann Rheum Dis
1 BMJ
6 Clin Exp Rheumatol
4 Clin Rheumatol
1 Eur J Radiol
4 PLoS One
2 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. BELKHIR R, Burel SL, Dunogeant L, Marabelle A, et al
    Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment.
    Ann Rheum Dis. 2017 Jun 9. pii: annrheumdis-2017-211216.
    PubMed     Text format     Abstract available

  2. EMERY P, Vencovsky J, Sylwestrzak A, Leszczynski P, et al
    A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:51-57.
    PubMed     Text format     Abstract available

  3. CHOE JY, Prodanovic N, Niebrzydowski J, Staykov I, et al
    A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.
    Ann Rheum Dis. 2017;76:58-64.
    PubMed     Text format     Abstract available

  4. HENSVOLD AH, Frisell T, Magnusson PK, Holmdahl R, et al
    How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins.
    Ann Rheum Dis. 2017;76:119-125.
    PubMed     Text format     Abstract available

  5. CAPPELLI LC, Gutierrez AK, Baer AN, Albayda J, et al
    Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.
    Ann Rheum Dis. 2017;76:43-50.
    PubMed     Text format     Abstract available

  6. SHIBOSKI CH, Shiboski SC, Seror R, Criswell LA, et al
    2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.
    Ann Rheum Dis. 2017;76:9-16.
    PubMed     Text format     Abstract available

  7. DOUGADOS M, van der Heijde D, Chen YC, Greenwald M, et al
    Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
    Ann Rheum Dis. 2017;76:88-95.
    PubMed     Text format     Abstract available

  8. COHEN S, Genovese MC, Choy E, Perez-Ruiz F, et al
    Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210459.
    PubMed     Text format     Abstract available

  9. THOMSEN T, Aadahl M, Beyer N, Hetland ML, et al
    The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial.
    Ann Rheum Dis. 2017 Jun 5. pii: annrheumdis-2016-210953.
    PubMed     Text format     Abstract available

  10. KREMER JM, Weinblatt ME
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211632.
    PubMed     Text format    

  11. HUMPHREYS JH, Costello R, Verstappen SM, Dixon WG, et al
    Response to: Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis by Kremer and Weinblatt.
    Ann Rheum Dis. 2017 Jun 8. pii: annrheumdis-2017-211670.
    PubMed     Text format    


    BMJ

  12. CHEN L, Michalsen A
    Management of chronic pain using complementary and integrative medicine.
    BMJ. 2017;357:j1284.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  13. GADEHOLT O
    Rheumatoid arthritis is not a single disease.
    Clin Exp Rheumatol. 2017;35 Suppl 104:20-21.
    PubMed     Text format     Abstract available

  14. LESUIS N, van Vollenhoven RF, Akkermans RP, Verhoef LM, et al
    Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  15. MASI AT, Rehman AA, Jorgenson LC, Aldag JC, et al
    Preclinical biomarker associations with both incident rheumatoid arthritis and its subsequent mortality: sex effects in a 41-year, community-based, case-control cohort study.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  16. MARRIE RA, Hitchon CA, Peschken CA, Chen H, et al
    Health care utilisation before and after intensive care unit admission in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  17. BELL DA, Elhayek S, Cairns E, Barra L, et al
    Anti-homocitrullinated protein antibody isotype usage in rheumatoid arthritis and their unaffected first-degree relatives.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  18. LEON L, Gomez A, Vadillo C, Pato E, et al
    Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  19. XIE X, Li F, Li S, Tian J, et al
    Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis.
    Clin Rheumatol. 2017 Jun 10. doi: 10.1007/s10067-017-3639.
    PubMed     Text format     Abstract available

  20. ROJAS-SERRANO J, Herrera-Bringas D, Perez-Roman DI, Perez-Dorame R, et al
    Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
    Clin Rheumatol. 2017 Jun 6. doi: 10.1007/s10067-017-3707.
    PubMed     Text format     Abstract available

  21. SAG S, Sag MS, Tekeoglu I, Kamanli A, et al
    Nailfold videocapillaroscopy results in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Jun 4. doi: 10.1007/s10067-017-3696.
    PubMed     Text format     Abstract available

  22. VOS I, Van Mol C, Trouw LA, Mahler M, et al
    Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays.
    Clin Rheumatol. 2017 Jun 3. doi: 10.1007/s10067-017-3684.
    PubMed     Text format     Abstract available


    Eur J Radiol

  23. THUERMEL K, Neumann J, Jungmann PM, Schaffeler C, et al
    Fluorescence optical imaging and 3T-MRI for detection of synovitis in patients with rheumatoid arthritis in comparison to a composite standard of reference.
    Eur J Radiol. 2017;90:6-13.
    PubMed     Text format     Abstract available


    PLoS One

  24. MORI S, Yoshitama T, Hidaka T, Sakai F, et al
    Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
    PLoS One. 2017;12:e0179179.
    PubMed     Text format     Abstract available

  25. MATEEN S, Moin S, Shahzad S, Khan AQ, et al
    Level of inflammatory cytokines in rheumatoid arthritis patients: Correlation with 25-hydroxy vitamin D and reactive oxygen species.
    PLoS One. 2017;12:e0178879.
    PubMed     Text format     Abstract available

  26. MOOTS RJ, Xavier RM, Mok CC, Rahman MU, et al
    Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventi
    PLoS One. 2017;12:e0179308.
    PubMed     Text format     Abstract available

  27. BUONDONNO I, Rovera G, Sassi F, Rigoni MM, et al
    Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study.
    PLoS One. 2017;12:e0178463.
    PubMed     Text format     Abstract available


    Rheumatol Int

  28. CARDENAS MJ, de la Fuente S, Castro-Villegas MC, Romero-Gomez M, et al
    Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3757.
    PubMed     Text format     Abstract available

  29. PAVELKA K, Akkoc N, Al-Maini M, Zerbini CAF, et al
    Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access.
    Rheumatol Int. 2017 Jun 9. doi: 10.1007/s00296-017-3749.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: